Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Lung Cancer

  Free Subscription


Articles published in Am J Clin Oncol

Retrieve available abstracts of 19 articles:
HTML format



Single Articles


    May 2025
  1. GILMORE LA, Willmann J, Olaechea S, Gilmore BW, et al
    Prevalence and Development of Cachexia Before and After Diagnosis of Non-small Cell Lung Cancer.
    Am J Clin Oncol. 2025 May 5. doi: 10.1097/COC.0000000000001211.
    PubMed     Abstract available


    December 2024
  2. SANCHEZ JI, Doose M, Zeruto C, Chollette V, et al
    Assessing the Impact of Multidisciplinary Cancer Consultations on Cancer Quality Metrics.
    Am J Clin Oncol. 2024;47:595-606.
    PubMed     Abstract available


    November 2024
  3. SHAH A, Apple J, Aslam S, Engel-Nitz NM, et al
    Complications, Costs, and Health Care Resource Use with Tissue Biopsy Followed by Liquid Biopsy Versus Tissue Re-biopsy in Patients With Newly Diagnosed Metastatic Nonsmall-cell Lung Cancer.
    Am J Clin Oncol. 2024 Nov 5. doi: 10.1097/COC.0000000000001155.
    PubMed     Abstract available


    October 2024
  4. GUMUSTEPE E, Yavas G, Kirakli EK, Dincbas FO, et al
    Prognostic Impact of Low Muscle Mass and Inflammatory Markers in Stage III Nonsmall Cell Lung Cancer Turkish Oncology Group and Turkish Society of Radiation Oncology Thoracic Cancer Study Group (08-005).
    Am J Clin Oncol. 2024 Oct 22. doi: 10.1097/COC.0000000000001152.
    PubMed     Abstract available


    September 2024
  5. QURESHI Z, Altaf F, Jamil A, Siddique R, et al
    Meta-analysis of Targeted Therapies in EGFR-mutated Non-Small Cell Lung Cancer: Efficacy and Safety of Osimertinib, Erlotinib, and Gefitinib as First-line Treatment.
    Am J Clin Oncol. 2024 Sep 11. doi: 10.1097/COC.0000000000001138.
    PubMed     Abstract available


    June 2024
  6. LIU C, Gao F, Yang J, Liu C, et al
    Wilms' Tumor 1-Associating Protein Promotes Nonsmall-Cell Lung Cancer Through the Expression of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5.
    Am J Clin Oncol. 2024 Jun 20. doi: 10.1097/COC.0000000000001116.
    PubMed     Abstract available


  7. XU J, Tian L, Qi W, Lv Q, et al
    Advancements in NSCLC: From Pathophysiological Insights to Targeted Treatments.
    Am J Clin Oncol. 2024;47:291-303.
    PubMed     Abstract available


    May 2024
  8. ZHANG T, Hu Y, Yang N, Yu S, et al
    The microRNA-34 Family and Its Functional Role in Lung Cancer.
    Am J Clin Oncol. 2024 May 3. doi: 10.1097/COC.0000000000001106.
    PubMed     Abstract available


  9. KASHIWABARA K, Fujii S, Tsumura S, Tokunaga R, et al
    Feasibility, Tolerability, and Effectiveness of Transbronchial Interventions in Elderly Patients With Malignant Central Airway Obstruction: A Retrospective Single-institution Study.
    Am J Clin Oncol. 2024;47:223-227.
    PubMed     Abstract available


    April 2024

  10. Pretreatment Characteristics of Carcinoid Tumors of the Lung Which Predict Aggressive Behavior: Erratum.
    Am J Clin Oncol. 2024;47:e1.
    PubMed    


  11. LIU X, Shen Q, Wen Y, Jiang Z, et al
    Diagnosis of Malignant Pulmonary Nodules Using a Combination of Tumor-associated Autoantibodies and Computed Tomography.
    Am J Clin Oncol. 2024;47:149-154.
    PubMed     Abstract available


    January 2024
  12. CHOU B, Lee JH, Saetern L, Venkatesulu BP, et al
    Bombarding Oligoprogression: Oncologic Outcomes After Radiation to Patients With Oligoprogressive Non-Small Cell Lung Cancer on Maintenance Systemic Therapy.
    Am J Clin Oncol. 2024 Jan 9. doi: 10.1097/COC.0000000000001077.
    PubMed     Abstract available


    December 2023
  13. BRASCHI EL, Morris CG, Yeung AR, De Leo AN, et al
    Impact of Maximum Point Dose Within the Planning Target Volume on Local Control of Nonsmall Cell Lung Cancer Treated With Stereotactic Body Radiotherapy.
    Am J Clin Oncol. 2023 Dec 25. doi: 10.1097/COC.0000000000001081.
    PubMed     Abstract available


    November 2023
  14. ALVAREZ CM, Aliru M, Gannavarapu BS, Song T, et al
    Impact of Pretreatment Weight Loss on Radiotherapy Utilization and Clinical Outcomes in Non-Small Cell Lung Cancer.
    Am J Clin Oncol. 2023 Nov 24. doi: 10.1097/COC.0000000000001053.
    PubMed     Abstract available


  15. YANG L, Lu X, Luo J, Huang D, et al
    Hyperfractionated Accelerated Radiotherapy Versus Stereotactic Body Radiotherapy in the Treatment of Limited-Stage Small Cell Lung Cancer: A Matched-Pair Analysis.
    Am J Clin Oncol. 2023 Nov 20. doi: 10.1097/COC.0000000000001066.
    PubMed     Abstract available


  16. CANTRELL JN, Acharya P, Vesely SK, Gunter TC, et al
    Pathologic Nodal Staging Before SBRT for Early-stage NSCLC Does Not Impact Overall Survival: A Propensity Score-matched NCDB Analysis.
    Am J Clin Oncol. 2023;46:503-511.
    PubMed     Abstract available


    October 2023
  17. ZHAO KX, Zhang YF, Zheng L, Pan YF, et al
    A Meta-analysis of Randomised Controlled Trials Comparing Combination Therapy as Second-line Treatment With Monotherapy in Advanced Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutation.
    Am J Clin Oncol. 2023 Oct 2. doi: 10.1097/COC.0000000000001047.
    PubMed     Abstract available


    September 2023
  18. YU S, Zhai S, Gong Q, Xiang C, et al
    Neoadjuvant Immunotherapy and Non-Small Cell Lung Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Am J Clin Oncol. 2023 Sep 26. doi: 10.1097/COC.0000000000001046.
    PubMed     Abstract available


  19. ACIKGOZ Y, Yildirim FU, Esen SA, Ucar G, et al
    The Prognostic and Functional Impact of Sprouty 2 Expression in Non-small Cell Lung Cancer.
    Am J Clin Oncol. 2023 Sep 13. doi: 10.1097/COC.0000000000001044.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.